initially a lenalidomide-dexamethasone-ixazomib induction regimen during four cycles, followed by high dose melphalan at 200 mg/m 2 and autologous stem cell transplantation 48 hours later. He presented pneumonia and sepsis 2 weeks after stem cell transplantation. He received a consolidation regimen 3 months after (two cycles of lenalidomide-dexamethasone) then maintenance treatment by lenalidomide during 6 months. The patient showed partial response to treatment according to the international response criteria. The patient also displayed thrombocytopenia related to bone marrow plasma cell infiltration and drug toxicity. Iterative platelet infusions did not correct thombocytopenia.
In April 2017, the patient underwent surgery for an L2 vertebra fracture. He relapsed afterward in May 2017, October 2017, and January 2018. These three successive relapses were treated with lenalidomide-dexamethasone-daratumumab, with pomalinomide-dexamethasone, and with bortezomib-adriamycin-dexamethasone, respectively.
In While recovering from pulmonary infection, the patient's neurological condition worsened, with a transient loss of consciousness. He had no history of cerebral involvement, and no lumbar puncture had been performed before. All tests for infection and autoimmunity in the cerebrospinal fluid (CSF) were negative. The EEG under propofol was normal and reactive. However, in addition to already known diffuse vertebral infiltration, cerebral and spinal MRI showed an infiltrating lesion of the clivus spreading to the cavernous and sphenoidal sinuses and internal carotid sheathing (see Figure  1 , panel A). Retrospectively, hyperfixation of the clivus with increasing choline uptake between June and October 2017 was identified on the PET-CT scan (Figure 1, panel B) . The CSF obtained by lumbar puncture displayed a xantochromic honey-like appearance, macroscopically similar to a serum sample (Figure 1, panel C) Table 1 ). The patient died of multiple organ failure within a few days of admission to hospital.
| DISCUSSION
Extramedullary involvement is observed in about 7% of MM patients at diagnosis, while another 6% develop extramedullary lesions later in the course of the disease. Involvement of the CNS is estimated to be present in 1% of patients. The definitive diagnosis is histological, depending on the presence of atypical plasma cells in the CSF or direct tissue sampling. However, CSF cytology is poorly sensitive. An indirect diagnosis requires radiologically proven plasmacytoma arising in a location noncontiguous with the bone, that is, leptomeningeal enhancement and/or an intraparenchymal lesion. [1] [2] [3] [4] In such cases, intrathecal production of the monoclonal immunoglobulin or plasma cell by-products provides the rationale for CSF FLC measurement. This test has been reported to be more sensitive than cytology and to correlate with the response to therapy. 5 Moreover, such intrathecal synthesis can lead to markedly elevated proteinorachia. 6 The present case did not fit the canonical description of CNS involvement during MM: In spite of neurological symptoms that occurred at MM relapse, which strongly suggested CNS involvement, no plasma cells could be detected in the CSF. Imaging showed no leptomeningeal or parenchymal enhancement. Moreover, there was no elevation of the involved FLC or β2-microglobulin in the CSF as compared to serum. On the other hand, cerebral MRI revealed an infiltrating lesion of the clivus spreading to the cavernous and sphenoidal sinuses and internal carotid sheathing. Another striking feature of this case is the remarkably elevated nonselective proteinorachia (45 g/L), in the absence of radiological signs of intracranial hemorrhage. Blood uptake during lumbar puncture could be ruled out since only a few red blood cells were present in the CSF sample.
Two mechanisms, not mutually exclusive, may be envisaged to explain such elevated nonselective proteinorachia: an increase in the passage of serum proteins into the CSF or a decrease in protein clearance in the CSF. Traditional views consider that the CSF is mainly produced by the choroid plexus and to a lesser extent at the blood-brain barrier. Water, solutes, and cells then flow through the ventricular system and/ or the extracellular space of the brain into the subarachnoid space, from where the CSF flows out of the CNS through the arachnoid villi into the dural venous sinuses. Sheaths around the cranial nerves provide an alternative pathway for CSF outflow, predominantly through the cribriform plate, into the lymphatic system of the nasal mucosa, draining the deep cervical lymph nodes. 7, 8 The relative contributions of these two pathways remain poorly known. 9 The most frequent interpretation of an increased protein concentration in the CSF is the so-called "protein leakage" from the serum characterizing barrier impairment. Actually, it has been shown convincingly that a reduced CSF turnover is in most cases able to explain the presence of increased levels of blood-derived proteins in the CSF. A reduced CSF flow may be due to a lower CSF production rate (eg, induced by carbonic anhydrase inhibitors), or a lower outflow on account of local mechanical (eg, protein complexes), inflammatory or tumoral obstruction of the CSF outflow pathways. 10 Considering this case, it was believed at first that this patient presented intrathecal synthesis of FLC, given the very high concentration of FLC in the CSF. If the participation of such intrathecal synthesis in the elevated paraproteinorachia cannot be formally discarded in this case, it cannot either entirely explain the strikingly high and unselective proteinorachia. Rather more, impairment of the CSF outflow through the cribriform plate and cranial nerve sheaths might explain the markedly elevated proteinorachia and the neurological symptoms. In addition, although measurement of FLC in the CSF can provide useful information concerning suspected plasma cell dyscrasia with CNS involvement, 5 this method
is not yet standardized. In the absence of reference values, it requires confirmation using other analytical methods for the determination of CSF proteins such as immunofixation.
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| CONCLUSION
Very high proteinorachia can occur in myeloma patients without meningitis. In this case, we suspect that it was related to a mechanical obstruction caused by tumoral clivus infiltration, rather than intrathecal synthesis. Clonal free light chain was increased in the CSF, but to the same extent as in the serum.
